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Disseminated Penicilliosis in a Korean Human Immunodeficiency 
Virus Infected Patient from Laos
Penicillium marneffei may cause life-threatening systemic fungal infection in immune-
compromised patients and it is endemic in Southeast Asia. A 39-yr-old HIV-infected male, 
living in Laos, presented with fever, cough, and facial vesiculopapular lesions, which had 
been apparent for two weeks. CT scans showed bilateral micronodules on both lungs; 
Pneumocystis jirovecii was identified by bronchoscopic biopsy. Despite trimethoprim-
sulfamethoxazole and anti-tuberculosis medications, the lung lesions progressed and the 
facial lesions revealed central umbilications. Biopsy of the skin lesions confirmed 
disseminated penicilliosis, with the culture showing P. marneffei hyphae and spores. The 
P. marneffei was identified by rRNA PCR. A review of the bronchoscopic biopsy indicated 
penicilliosis. The patient completely recovered after being prescribed amphotericin-B and 
receiving antiretroviral therapy. This is the first case of penicilliosis in a Korean HIV-infected 
patient. It is necessary to consider P. marneffei when immunocompromised patients, with 
a history of visits to endemic areas, reveal respiratory disease.
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INTRODUCTION 
Penicillium marneffei can cause a life-threatening systemic fun-
gal infection in human immunodeficiency virus (HIV)-infected 
patients, and is prevalent in Southeast Asia, including Thailand, 
northeastern India, southern China, Hong Kong, Vietnam, and 
Taiwan. In 1956, the first P. marneffei isolation was reported in 
the bamboo rat’s liver (1) and the first human infection was in a 
61-yr-old American missionary who lived in Southeast Asia and 
suffered from Hodgkin’s lymphoma in 1973 (2). In 1988, the first 
disseminated P. marneffei infection case was reported in a HIV-
infected patient (3). P. marneffei might cause systemic infection 
in an immunocompetent host, but most of the reported cases 
of disseminated infection were related to HIV-infected patients.
  In endemic areas, the P. marneffei infection is regarded as an 
acquired immune deficiency syndrome (AIDS) marker, or an 
“AIDS defining illness,” following tuberculosis and cryptococ-
cosis in frequency (4). However, as overseas travel increases, 
sporadic cases of P. marneffei infection have been reported 
among Americans, Europeans, Australians, Japanese, and Afri-
cans who resided in or visited the endemic areas (5).
  Here we report on the first case of P. marneffei in a Korean 
HIV-infected patient who had been living in the endemic area. 
The infection was confirmed as penicilliosis through fungal cul-
ture and molecular analysis.
CASE DESCRIPTION
A 39-yr-old male patient visited the emergency room on May 
24, 2010 with fever, cough, and multiple papules that had been 
on his face for two weeks. He had been managing a farm in Laos 
for four years. He was told that he had been infected with HIV 
and miliary tuberculosis was suspected after a chest computed 
tomography (CT) scan at a hospital in Thailand. The patient de-
nied any history of homosexual contact. Upon arrival at the emer-
gency room, his mental status was alert and the diffuse vesicu-
lopapular lesions were easily observed on face. His vital signs 
were: blood pressure of 151/90 mmHg, a body temperature of 
37.1°C, a heart rate of 116 beats per minute, and a respiration 
rate of 27 breaths per minute. His oxygen saturation was 90% and 
arterial blood gas analysis revealed pH 7.46, PaCO2 34 mmHg, 
PaO2 55 mmHg, and HCO3 24 mM on room air. His breathing 
sounds were coarse with crackles in the bilateral lung field. Upon 
laboratory examination, his complete blood cell counts were: 
white blood cell count 4,100/μL (neutrophil 92.0%, lymphocytes 
4.8%), hemoglobin 11.4 g/dL, and platelet 134,000/μL, while 
erythrocyte sedimentation rate and C-reactive protein were 114 
mm/hr and 90 mg/L, respectively. Peripheral CD4+ T lympho-
cyte count and HIV-RNA viral load were 7 cells/μL and 457,392 
copies/mL. A chest X-ray revealed diffuse reticulonodular opac-
ities in the entire lung field. Chest CT scans revealed bilaterally Jung JY, et al.  •  A Korean HIV Infected Patient with Disseminated Penicilliosis 
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distributed micronodules and consolidation with a ground-glass 
opacity pattern on a dependent portion of his lungs (Fig. 1A). 
Suspecting tuberculosis, anti-tuberculosis medications of iso-
niazid, rifampin, ethambutol, and pyrazinamide were started. 
In addition, the results of the trans-bronchoscopic lung biopsy 
were initially reported as Pneumocystis jirovecii and trime-
thoprim-sulfamethoxazole was added to his regimen. One week 
after admission, vesiculopapular facial lesions exhibited central 
hemorrhagic changes (Fig. 1B) and spread to the neck, trunk, 
and upper extremities. A skin biopsy was performed, which re-
vealed massive dermatophytosis and fungal abscess. Deoxy-
cholate amphotericin-B (0.7 mg/kg) was started and antiretro-
A B
Fig. 1. Clinical features of disseminated P. marneffei infection. (A) Initial chest CT findings. Bilaterally distributed multiple small nodules and consolidation with ground-glass 
opacity pattern were observed in dependent portions. (B) Skin lesions one week after admission. Multiple erythematous papular lesions in forehead revealed central umbilication.
A B
Fig. 2. Penicillium marneffei cultured at 25°C on Sabouraud dextrose agar plate. (A) Gross findings of culture. Colonies revealed distinctive red diffusible pigment and the surface 
was powdery and gray-green with a white border. (B) Microscopic findings. Lactophenol cotton blue stain preparation from colony revealed metulae and conidia of Penicillium 
marneffei.Jung JY, et al.  •  A Korean HIV Infected Patient with Disseminated Penicilliosis 
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viral therapy (ART) with abacavir, lamivudine, and efavirenz was 
also implemented for the treatment of HIV infection. Consider-
ing the typical skin lesions and fungal organisms in the biopsy, 
a disseminated P. marneffei infection was suspected. Fungal 
culture of skin tissue obtained by biopsy revealed colonies of 
green-gray belts with red pigmentation in Sabouraud dextrose 
agar plate (Fig. 2A) and mycelia was seen in the microscopic ex-
amination after staining with Lactophenol cotton blue by touch-
ing clear scotch tape to the colony (Fig. 2B). To identify the fun-
gal species, we performed sequencing of the internal transcribed 
spacer (ITS) and 26S rRNA gene regions. The ITS region (includ-
ing the 5.8S rRNA gene) and the 26S rRNA gene D1/D2 domains 
were amplified with the primer pairs of pITS-F/pITS-R and NL1/ 
NL4, respectively (6). Sequence similarity searches were per-
formed using basic local alignment search tool (BLAST), which 
revealed a complete (100%) match with P. marneffei. After 10 
days of amphotericin-B administration, the patient exhibited 
clinical and radiological improvement. The amphotericin-B was 
changed to oral itraconazole at 400 mg/day after 14 days of the 
amphotericin-B treatment. After eight weeks, the dose of itra-
conazole was modified to 200 mg/day and was maintained for 
an additional six months. The patient continues to visit an out-
patient clinic without any specific problems.
DISCUSSION
We reported the first case of P. marneffei in a Korean, HIV-in-
fected patient who had lived in a P. marneffei endemic area. Pri-
mary human infections of P. marneffei have been known to be 
acquired by inhalation of spores from soil which are then dis-
seminated to the skin, the reticuloendothelial system and the 
gut by hematogenous spread and other organ systems. Penicil-
liosis in HIV-infected patients may be misdiagnosed as Myco-
bacterium tuberculosis because multiple nodules and mediasti-
nal lymphadenopathy are radiologic findings of penicilliosis (7, 
8). Fungal cultures or direct staining of infected tissues is required 
to differentiate penicilliosis from tuberculosis.
  In addition, diffuse alveolar shadows have been observed in 
about 10% of patients infected with P. marneffei (4, 9), which 
may reveal intense parenchymal opacification like acute respi-
ratory distress syndrome. Therefore, penicilliosis may also be 
misdiagnosed as Pneumocystis jirovecii pneumonia (PCP) (10). 
PCP rarely reveals pleural effusions, while P. marneffei infection 
sometimes accompany pleural effusion. Sputum examination 
may also be helpful to differentiate PCP from a P. marneffei in-
fection (11, 12).
  In our case, an initial chest CT scan showed bilaterally dis-
tributed micronodules and consolidation with a diffuse ground-
glass opacity pattern and a trans-bronchoscopic lung biopsy 
result was initially misinterpreted as Pneumocystis jirovecii. There-
fore, we suspected a pulmonary tuberculosis and PCP co-infec-
tion. Clinical improvement, however, was not obvious despite 
anti-tuberculosis medication and trimethoprim-sulfamethoxa-
zole administration. This led us to suspect the P. marneffei in-
fection, considering typical skin lesions revealed fungal organ-
isms in the biopsy and an aggravated pulmonary infiltration.
  Unlikely pulmonary presentations, skin lesions are relatively 
characteristic in penicilliosis. The proportion of patients with 
skin lesion has been reported between 28% and 71% in dissem-
inated penicilliosis (4, 9). Skin lesions present as multiple flesh-
colored, dome-shaped papules in the early stage, similar to mol-
luscum contagiosum (13). However, simple papules observed 
on the face, trunk, neck and extremities frequently ulcerate over 
time and change with central necrotic umbilication (5, 14). Mol-
luscum contagiosum resolves by itself in six months to two years 
in HIV-infected patients in accordance with immune function 
improvement after ART. But skin lesions of P. marneffei are not 
expected to improve without active antifungal treatment. 
  P. marneffei mainly affects people with impaired cellular im-
munity (i.e. HIV-infected patients) (15) and the severity and 
clinical manifestations depend on the patient’s immunity (16). 
In patients with normal immunity, P. marneffei mostly causes 
mild and localized infections, but it can cause severe dissemi-
nated infections with generalized lymphadenopathy and per-
sistent fever in immunocompromised HIV-infected patients (5). 
It is known that the prognosis of penicilliosis can be improved if 
immunity could be recovered during the antifungal treatment 
in immunocompromised patients (9, 15). 
  There have been two case reports of P. marneffei infection in 
the Republic of Korea. One case was a continuous ambulatory 
peritoneal dialysis-associated peritonitis which revealed im-
provement after catheter removal and antifungal therapy (17). 
The second case was a disseminated P. marneffei infection which 
occurred after a visit to China to receive a liver transplant, and 
that area of China is a P. marneffei endemic area (18). This pa-
tient was taking immunosuppressive therapy of tacrolimus and 
mycophenolate. Lymphocytopenia, which is considered a mark-
er of impaired cellular immunity, was observed in both the liver 
transplant recipient (lymphocyte count 410 cells/μL) and our 
HIV-infected patient (lymphocyte count 197 cells/μL, CD4+ T 
lymphocyte count 7 cells/μL). While both patients also exhibit-
ed a disseminated P. marneffei infection, the liver transplant re-
cipient died due to refractory viral and bacterial infections, de-
spite intensive treatment. In previous reports, the mortality rate 
of patients with P. marneffei infection was reported as 13.5% (7/ 
52) in HIV-infected patients and 60% (6/10) in non-HIV infected 
patients (9, 15). In our case, the patient exhibited a good clinical 
outcome although he initially presented severe disseminated 
penicilliosis. We suppose that recovery depends upon the im-
mune recovery related with ART and is similar to findings of pre-
vious studies which revealed a better outcome in HIV-infected 
penicilliosis patients compared to the non-HIV-infected patients.Jung JY, et al.  •  A Korean HIV Infected Patient with Disseminated Penicilliosis 
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  The authors experienced the first case of P. marneffei in a 
Korean HIV-infected patient. We suppose that it is important to 
consider P. marneffei when immunocompromised patients with 
histories of visits to areas of endemicity reveal respiratory dis-
ease, generalized lymphadenopathy, and central umbilicated 
vesicular skin lesions.
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